Biodroga

Shares of Neptune Technologies & Bioressources (NASDAQ: NEPT), a biotechnology company that focuses on the development of marine-derived omega-3 polyunsaturated fatty acids (PUFAs), spiked by more than 5 percent before selling off. Neptune announced preliminary results for the fourth quarter...